Fla. Stat. 465.1893
Administration of antipsychotic medication by injection


(1)(a)

A pharmacist, at the direction of a physician licensed under chapter 458 or chapter 459, may administer a long-acting antipsychotic medication approved by the United States Food and Drug Administration by injection to a patient if the pharmacist:
Is authorized by and acting within the framework of an established protocol with the prescribing physician.
Practices at a facility that accommodates privacy for nondeltoid injections and conforms with state rules and regulations regarding the appropriate and safe disposal of medication and medical waste.
Has completed the course required under subsection (2).
A separate prescription from a physician is required for each injection administered by a pharmacist under this subsection.

(1)(a)

A pharmacist, at the direction of a physician licensed under chapter 458 or chapter 459, may administer a long-acting antipsychotic medication approved by the United States Food and Drug Administration by injection to a patient if the pharmacist:Is authorized by and acting within the framework of an established protocol with the prescribing physician.Practices at a facility that accommodates privacy for nondeltoid injections and conforms with state rules and regulations regarding the appropriate and safe disposal of medication and medical waste.Has completed the course required under subsection (2).
1. Is authorized by and acting within the framework of an established protocol with the prescribing physician.
2. Practices at a facility that accommodates privacy for nondeltoid injections and conforms with state rules and regulations regarding the appropriate and safe disposal of medication and medical waste.
3. Has completed the course required under subsection (2).

(b)

A separate prescription from a physician is required for each injection administered by a pharmacist under this subsection.

(2)(a)

A pharmacist seeking to administer a long-acting antipsychotic medication by injection must complete an 8-hour continuing education course offered by:
A statewide professional association of physicians in this state accredited to provide educational activities designated for the American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 Credit or the American Osteopathic Association (AOA) Category 1-A continuing medical education (CME) credit; and
A statewide association of pharmacists.
The course may be offered in a distance learning format and must be included in the 30 hours of continuing professional pharmaceutical education required under s. 465.009(1). The course shall have a curriculum of instruction that concerns the safe and effective administration of behavioral health and antipsychotic medications by injection, including, but not limited to, potential allergic reactions to such medications.

(2)(a)

A pharmacist seeking to administer a long-acting antipsychotic medication by injection must complete an 8-hour continuing education course offered by:A statewide professional association of physicians in this state accredited to provide educational activities designated for the American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 Credit or the American Osteopathic Association (AOA) Category 1-A continuing medical education (CME) credit; andA statewide association of pharmacists.
1. A statewide professional association of physicians in this state accredited to provide educational activities designated for the American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 Credit or the American Osteopathic Association (AOA) Category 1-A continuing medical education (CME) credit; and
2. A statewide association of pharmacists.

(b)

The course may be offered in a distance learning format and must be included in the 30 hours of continuing professional pharmaceutical education required under s. 465.009(1). The course shall have a curriculum of instruction that concerns the safe and effective administration of behavioral health and antipsychotic medications by injection, including, but not limited to, potential allergic reactions to such medications.

Source: Section 465.1893 — Administration of antipsychotic medication by injection, https://www.­flsenate.­gov/Laws/Statutes/2024/0465.­1893 (accessed Aug. 7, 2025).

465.001
Short Title
465.002
Legislative findings
465.003
Definitions
465.004
Board of Pharmacy
465.005
Authority to make rules
465.006
Disposition of fees
465.007
Licensure by examination
465.008
Renewal of license
465.009
Continuing professional pharmaceutical education
465.012
Reactivation of license
465.013
Registration of pharmacy interns
465.014
Pharmacy technician
465.015
Violations and penalties
465.016
Disciplinary actions
465.017
Authority to inspect
465.018
Community pharmacies
465.019
Institutional pharmacies
465.022
Pharmacies
465.023
Pharmacy permittee
465.024
Promoting sale of certain drugs prohibited
465.025
Substitution of drugs
465.026
Filling of certain prescriptions
465.027
Exceptions
465.035
Dispensing of medicinal drugs pursuant to facsimile of prescription
465.0075
Licensure by endorsement
465.0125
Consultant pharmacist license
465.0126
Nuclear pharmacist license
465.0155
Standards of practice
465.0156
Registration of nonresident pharmacies
465.0157
International export pharmacy permit
465.0158
Nonresident sterile compounding permit
465.0161
Distribution of medicinal drugs without a permit
465.0181
Community pharmacy permit required to dispense Schedule II or Schedule III controlled substances
465.185
Rebates prohibited
465.186
Pharmacist’s order for medicinal drugs
465.187
Sale of medicinal drugs
465.188
Medicaid audits of pharmacies
465.189
Administration of vaccines and epinephrine autoinjection
465.0193
Nuclear pharmacy permits
465.0196
Special pharmacy permits
465.0197
Internet pharmacy permits
465.0235
Automated pharmacy systems used by long-term care facilities, hospices, or state correctional institutions, or for outpatient dispensing
465.0244
Information disclosure
465.0251
Generic drugs
465.0252
Substitution of interchangeable biosimilar products
465.0255
Expiration date of medicinal drugs
465.0265
Centralized prescription filling
465.0266
Common database
465.0275
Emergency prescription refill
465.0276
Dispensing practitioner
465.1861
Ordering and dispensing HIV infection prevention drugs
465.1865
Collaborative pharmacy practice for chronic health conditions
465.1893
Administration of antipsychotic medication by injection
465.1895
Testing or screening for and treatment of minor, nonchronic health conditions
465.1901
Practice of orthotics and pedorthics
465.1902
Prescription Drug Donation Repository Program

Current through Fall 2025

§ 465.1893. Admin. of antipsychotic medication by injection's source at flsenate​.gov